Literature DB >> 28992893

Translation and validation of the Dutch version of the Fear of Cancer Recurrence Inventory (FCRI-NL).

Sanne Jasperine van Helmondt1, Marije Liesbeth van der Lee2, Jolanda de Vries3.   

Abstract

OBJECTIVE: The study objectives are to translate the FCRI in Dutch, and to explore the factor structure and the psychometric qualities of the Dutch translation of the Fear of Cancer Recurrence Inventory (FCRI-NL).
METHOD: The original French-Canadian FCRI had been forward-backward translated into English by the developers, and this method was also used to translate the English version of the FCRI into Dutch. Patients were recruited via patient organizations between July 2011 and October 2013. To replicate the original 7-factor structure of the FCRI, confirmatory factor analysis (CFA) was performed. To examine the psychometric qualities, reliability (Cronbach's alpha), test-retest reliability (intra-class correlations; ICC), and convergent and divergent validity (Spearman's correlations) were calculated.
RESULTS: From 290 cancer patients, 255 (88%) were eligible for analysis (aged 51.0±9.8years, 88.6% women). CFA showed a reasonable yet suboptimal fit of the hypothesized model to the data. The FCRI-NL has good reliability (Cronbach's α=0.93 for the total scale and α=0.75-0.92 for the subscales) and test-retest reliability (ICC=0.84 for the total scale and ICC=0.56-0.87 for the subscales). Convergent (r=0.53-0.66 for the FCRI-NL and r=0.48-0.57 for the FCRI-SF-NL) and divergent (r=-0.20--0.07 for the FCRI-NL and r=-0.28--0.17 for the FCRI-SF-NL) validity was demonstrated.
CONCLUSION: The FCRI-NL seems to have sufficient psychometric properties. However, the FCRI-NL total score should be interpreted with caution. The Severity subscale (FCRI-SF-NL) may be a valuable screening tool for fear of cancer recurrence severity in clinical care.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  Confirmatory factor analysis (CFA); Construct validity; Fear of Cancer Recurrence Inventory (FCRI); Fear of cancer recurrence; Internal consistency; Translation

Mesh:

Year:  2017        PMID: 28992893     DOI: 10.1016/j.jpsychores.2017.09.001

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  8 in total

1.  Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients.

Authors:  Ida Hovdenak Jakobsen; Mette Moustgaard Jeppesen; Sébastien Simard; Henriette Vind Thaysen; Søren Laurberg; Therese Juul
Journal:  J Cancer Surviv       Date:  2018-08-20       Impact factor: 4.442

2.  Prevalence and clinical and psychological correlates of high fear of cancer recurrence in patients newly diagnosed with head and neck cancer.

Authors:  Spela Mirosevic; Belinda Thewes; Carla van Herpen; Johannes Kaanders; Thijs Merkx; Gerry Humphris; Robert J Baatenburg de Jong; Johannes A Langendijk; C René Leemans; Chris H J Terhaard; Irma M Verdonck-de Leeuw; Robert Takes; Judith Prins
Journal:  Head Neck       Date:  2019-06-07       Impact factor: 3.147

3.  Fear of Cancer Recurrence, Health Anxiety, Worry, and Uncertainty: A Scoping Review About Their Conceptualization and Measurement Within Breast Cancer Survivorship Research.

Authors:  Christine Maheu; Mina Singh; Wing Lam Tock; Asli Eyrenci; Jacqueline Galica; Maude Hébert; Francesca Frati; Tania Estapé
Journal:  Front Psychol       Date:  2021-04-12

Review 4.  What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis.

Authors:  Yvonne L Luigjes-Huizer; Nina M Tauber; Gerry Humphris; Nadine A Kasparian; Wendy W T Lam; Sophie Lebel; Sébastien Simard; Allan Ben Smith; Robert Zachariae; Yati Afiyanti; Katy J L Bell; José A E Custers; Niek J de Wit; Peter L Fisher; Jacqueline Galica; Sheila N Garland; Charles W Helsper; Mette M Jeppesen; Jianlin Liu; Roxana Mititelu; Evelyn M Monninkhof; Lahiru Russell; Josée Savard; Anne E M Speckens; Sanne J van Helmondt; Sina Vatandoust; Nicholas Zdenkowski; Marije L van der Lee
Journal:  Psychooncology       Date:  2022-04-07       Impact factor: 3.955

5.  Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7.

Authors:  G M Humphris; E Watson; M Sharpe; G Ozakinci
Journal:  Health Qual Life Outcomes       Date:  2018-02-09       Impact factor: 3.186

6.  Study protocol of the BLANKET trial: a cluster randomised controlled trial on the (cost-) effectiveness of a primary care intervention for fear of cancer recurrence in cancer survivors.

Authors:  Yvonne L Luigjes-Huizer; Marije L van der Lee; Niek J de Wit; Charles W Helsper
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

7.  Predictors and Effects of Usage of an Online Mindfulness Intervention for Distressed Cancer Patients: Usability Study.

Authors:  Linda Cillessen; Monique Om van de Ven; Félix R Compen; Else M Bisseling; Marije L van der Lee; Anne Em Speckens
Journal:  J Med Internet Res       Date:  2020-10-02       Impact factor: 5.428

8.  Exploring Fear of Cancer Recurrence in a Sample of Heterogeneous Distressed Cancer Patients with and Without a Psychiatric Disorder.

Authors:  Else M Bisseling; Félix R Compen; Melanie P J Schellekens; Belinda Thewes; Anne E M Speckens; Marije L van der Lee
Journal:  J Clin Psychol Med Settings       Date:  2021-06-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.